Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Oncology·MeSH: Lymphoma, Follicular
Prevalence
20.0 / 100K
Incidence
4.7 / 100K/yr
0 drugs in development·0 companies·1 clinical trial
Frequently asked questions
How many clinical trials target Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)?
There are 1 clinical trial targeting Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) tracked by BioSniper.
What is the prevalence of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)?
The estimated prevalence of Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) is approximately 20.0 per 100,000 population.
Deep-dive into Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL)
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis